|
|
Pharmaceuticals
| ||||||||||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||||||||
|
Current Pharmaceuticals News Today NPS Pharmaceuticals to Present at Upcoming Conferences NPS Pharmaceuticals, Inc. is scheduled to present at the 14th Annual Bio CEO and Investor Conference in New York on Monday, February 13, 2012 at 9:30 a.m. ET and the Leerink Swann Global Healthcare Conference on Thursday, February 16, 2012 at 9:00 a.m. Mon, 06 Feb 2012 13:10:00 -0800 Astex Pharmaceuticals Announces Presentations at Upcoming Conferences Astex Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Mon, 06 Feb 2012 03:00:00 -0800 Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally ... Mon, 06 Feb 2012 14:00:00 -0800 Synta Pharmaceuticals Sells Additional 1,050,000 Shares of Common Stock Synta Pharmaceuticals Corp. today announced the completion of the sale of 1,050,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters of its previously announced public offering. Mon, 06 Feb 2012 13:11:00 -0800 Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan MISSISSAUGA, Ontario, Feb. 6, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl ... Mon, 06 Feb 2012 05:00:00 -0800 |
| Copyright 2006-2008 by Sleek Seo Web Directory All Rights Reserved Power : PHPLD |
